{
    "Trade/Device Name(s)": [
        "D3 DFA Cytomegalovirus Immediate Early Antigen Identification Kit"
    ],
    "Submitter Information": "Diagnostic Hybrids, Inc.",
    "510(k) Number": "K081164",
    "Predicate Device Reference 510(k) Number(s)": [
        "K951821",
        "K904036"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LIN"
    ],
    "Summary Letter Date": "June 18, 2008",
    "Summary Letter Received Date": "April 24, 2008",
    "Submission Date": "April 21, 2008",
    "Regulation Number(s)": [
        "21 CFR 866.3175"
    ],
    "Regulation Name(s)": [
        "Cytomegalovirus Serological Reagents"
    ],
    "Analyte Class(es)": [
        "virology"
    ],
    "Analyte(s)": [
        "Cytomegalovirus immediate early antigen (IEA)"
    ],
    "Specimen Type(s)": [
        "Cell culture"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Fluorescence microscope"
    ],
    "Method(s)/Technology(ies)": [
        "Immunofluorescence assay",
        "Fluorescein-labeled monoclonal antibodies"
    ],
    "Methodologies": [
        "Direct fluorescent antibody (DFA) staining"
    ],
    "Submission Type(s)": [
        "Kit",
        "Reagent",
        "Control Slide",
        "Mounting Fluid",
        "Buffer"
    ],
    "Document Summary": "FDA 510(k) summary for D3 DFA Cytomegalovirus Immediate Early Antigen Identification Kit for qualitative detection and identification of human CMV IEA in cell culture using immunofluorescence.",
    "Indications for Use Summary": "Intended for qualitative detection and identification of human cytomegalovirus immediate early antigen in cell cultures by immunofluorescence using fluoresceinated monoclonal antibodies; not for blood/plasma donor screening or direct detection in clinical specimens.",
    "fda_folder": "Microbiology"
}